Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
Filing tables
Filing exhibits
FRTX similar filings
Filing view
External links
Exhibit 31.3
CERTIFICATION PURSUANT TO RULE 13a-14(a) OR RULE 15d-14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934
I, Andrew D. Sklawer, certify that:
1.I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K/A of Fresh Tracks Therapeutics, Inc., a Delaware corporation; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Date: May 1, 2023 | By: | /s/ Andrew D. Sklawer | |||||||||
Andrew D. Sklawer | |||||||||||
Chief Executive Officer | |||||||||||
(Principal Executive Officer) |